AstraZeneca: COVID-19 vaccine ‘highly effective’ prevention

AstraZeneca: COVID-19 vaccine ‘highly effective’ prevention

November 23, 2020   03:24 pm


LONDON (AP) — AstraZeneca says late stage trials of its COVID-19 vaccine developed with Oxford University were “highly effective’’ in preventing disease. 

The results are based on interim analysis of trials in the U.K. and Brazil of the vaccine. 

Dr. Andrew Pollard said “these findings show that we have an effective vaccine that will save many lives.” 

He said if people were given a half dose followed by a full dose, rather than two full doses, protection rose to about 90%. 

Two other drugmakers, Pfizer and Moderna, have reported preliminary results showing that their COVID-19 vaccines were almost 95% effective. 

Yet the AstraZeneca-Oxford vaccine does not have to be stored at ultra-cold temperatures, making it far easier to distribute in developing countries.

Source: Associated Press


Disclaimer: All the comments will be moderated by the AD editorial. Abstain from posting comments that are obscene, defamatory or slanderous. Please avoid outside hyperlinks inside the comment and avoid typing all capitalized comments. Help us delete comments that do not follow these guidelines by flagging them(mouse over a comment and click the flag icon on the right side). Do use these forums to voice your opinions and create healthy discourse.

Most Viewed Video Stories